Randomized Double-Blind Study Comparing the Efficacy of Terazosin Versus Placebo in Women with Prostatism-Like Symptoms
Author:
Affiliation:
1. Department of Urology, New York University School of Medicine, New York, New York and Medical College of Wisconsin, Milwaukee, Wisconsin.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference10 articles.
1. A randomized placebo-controlled multicenter study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia;Lepor;J. Urol.,1992
2. Use of terazosin in the medical treatment of benign prostatic hyperplasia: experience in Italy;Di Silverio;Brit. J. Urol.,1992
3. Terazosin in the treatment of benign prostatic hyperplasia: a multicentre, placebo-controlled trial;Lloyd;Brit. J. Urol.,1992
4. A new look at bladder neck obstruction by the Food and Drug Administration regulators: guidelines for investigation of benign prostatic hypertrophy;Boyarsky;Trans. Amer. Ass. Genito-Urin. Surg.,1977
5. Symptom status and quality of life following prostatectomy;Fowler;J.A.M.A.,1988
Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Effect of symptom-based alpha-blocker treatment on lower urinary tract symptoms in women: systematic review and meta-analysis;Therapeutic Advances in Urology;2021-01
2. Place des alphabloquants chez la femme : revue de la littérature;Progrès en Urologie;2020-12
3. Re: Efficacy of an Alpha-Blocker for the Treatment of Nonneurogenic Voiding Dysfunction in Women: An 8-Week, Randomized, Double-Blind, Placebo-Controlled Trial;Journal of Urology;2020-01
4. Initial report on distribution of β3‐adrenoceptor in the human female urethra;Neurourology and Urodynamics;2019-10-14
5. Alpha-1 Adrenergic Receptor Blockers for the Treatment of Lower Urinary Tract Symptoms in Women: A Systematic Review and Meta-Analysis;International Neurourology Journal;2019-03-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3